# Test Results: fundamentals/chain-of-thought.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-23.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** fundamentals/chain-of-thought.md
- **Model:** nemotron-3-super-120b
- **Model ID (pinned):** Nemotron-3-Super-120B-A12B-NVFP4
- **Endpoint:** https://copilot-dev.cqls.oregonstate.edu/llm/nemotron3-super-120b-nvfp4/v1
- **Date:** 2026-06-23
- **Tester:** cross-model-harness
- **Assembly strategy:** concat
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
```
{TASK_DESCRIPTION}

Think through this step by step:
1. First, identify {RELEVANT_FACTORS}
2. Then, consider {KEY_CONSIDERATIONS}
3. Finally, {REACH_CONCLUSION}

Show your reasoning at each step before providing your final answer.

I need to select a statistical approach for analyzing my microbiome data. Here's my study:

- 20 mice, 10 per treatment group (probiotic vs. placebo)
- Fecal samples collected at 3 time points (days 0, 14, 28)
- Outcome: relative abundances of bacterial taxa (compositional data)
- Question: Does probiotic treatment affect community composition over time?
- Additional context: Some mice were co-housed (2-3 per cage), creating potential cage effects

Think through this step by step:

**Step 1 - Data structure:**
What are the key features of my data that affect analysis choice? Consider the experimental design, the nature of the outcome variable, and any dependencies in the data.

**Step 2 - Candidate approaches:**
What statistical approaches could address my question? For each, briefly note what it assumes and what it tests.

**Step 3 - Assumption evaluation:**
For each candidate approach, which assumptions might be problematic for my specific data structure?

**Step 4 - Practical considerations:**
What practical factors (software availability, interpretability, field conventions) should influence the choice?

**Step 5 - Recommendation:**
Based on the above, what approach or approaches would you suggest I discuss with a statistician? What specific questions should I ask them?

Show your reasoning explicitly at each step.
```

## Model Output
```


**Step 1 – Data structure**

| Feature | Why it matters for analysis |
|---------|-----------------------------|
| **Experimental design** – 2 treatment groups (probiotic vs. placebo), 10 mice per group, repeated measures at 3 time points (days 0, 14, 28). | Requires a method that can handle *within‑subject* (mouse) correlation over time and test a *group × time* interaction. |
| **Outcome** – Relative abundances of bacterial taxa (compositional data). | Data lie in a simplex; they are constrained (sum = 1) and exhibit spurious correlations. Standard linear models on raw proportions violate independence and normality assumptions. |
| **Dependencies** – Mice are nested within cages (2‑3 mice per cage). | Cage introduces a random effect (shared environment) that can induce extra correlation among mice beyond the repeated‑measure structure. Ignoring it inflates Type I error. |
| **Sample size** – Small‑moderate (N = 20). | Methods that rely on large‑sample asymptotics may be unreliable; permutation or resampling‑based approaches are attractive. |
| **Zero‑inflation / sparsity** – Many taxa may be absent in some samples. | Compositional methods that can handle zeros (e.g., pseudo‑counts, Bayesian multiplicative replacement) are needed. |

**Step 2 – Candidate approaches**

| Approach | Core idea / what it tests | Key assumptions |
|----------|--------------------------|-----------------|
| **1. Linear mixed‑effects model (LMM) on transformed data** (e.g., centered log‑ratio (CLR) or additive log‑ratio (ALR) of taxa) | Tests fixed effects of treatment, time, and their interaction; random intercepts for mouse (and optionally cage). | • Approx. normality of transformed abundances<br>• Homoscedastic residuals<br>• Random effects are normally distributed<br>• Independence conditional on random effects |
| **2. Generalized linear mixed model (GLMM) with Dirichlet‑multinomial or multinomial likelihood** | Models the count composition directly; tests treatment × time via fixed effects; random effects for mouse/cage. | • Counts follow Dirichlet‑multinomial (over‑dispersed multinomial)<br>• Random effects normally distributed on the log‑scale<br>• Correct specification of dispersion |
| **3. Distance‑based methods (PERMANOVA / adonis2) on dissimilarity matrices** (e.g., Bray‑Curtis, weighted UniFrac) | Tests whether centroids of groups differ over time; can include strata for repeated measures and cage as a blocking factor. | • Exchangeability under permutations (requires appropriate blocking/strata)<br>• Homogeneity of multivariate dispersions (checked via PERMDISP)<br>• Choice of distance metric reflects ecological question |
| **4. Mixed‑effects models on principal coordinates (PCoA) axes** (e.g., linear mixed model on first few PCoA scores) | Reduces dimensionality, then applies LMM to each axis; can test treatment × time on multivariate response via MANOVA or joint modeling. | • Axes approximate normality<br>• Linear relationships between predictors and scores<br>• Random effects normally distributed |
| **5. Bayesian hierarchical compositional models** (e.g., using `brms` or `Stan` with a logistic‑normal prior) | Fully probabilistic model for the simplex; includes random effects for mouse and cage; yields posterior distributions for treatment × time effects. | • Logistic‑normal assumption for latent proportions<br>• Prior choices reasonable<br>• MCMC convergence |
| **6. ANCOM‑BC / DESeq2‑style differential abundance with repeated‑measure extensions** | Tests individual taxa for treatment × time while controlling false discovery rate; can incorporate random effects via `lme4` or `dream`. | • Approx. normality of log‑ratios (ANCOM‑BC) or negative binomial counts (DESeq2)<br>• Adequate library size normalization<br>• Independence conditional on model |

**Step 3 – Assumption evaluation for each candidate**

| Approach | Potential problem with my data |
|----------|--------------------------------|
| **LMM on CLR/ALR** | CLR requires a pseudo‑count for zeros; with many zeros the transformation can be unstable. Small N may make normality of residuals questionable. Random effect for cage may be confounded with mouse if cage size is tiny (2‑3 mice). |
| **GLMM (Dirichlet‑multinomial)** | Directly models counts and over‑dispersion, handling zeros naturally. However, fitting a Dirichlet‑multinomial GLMM with crossed random effects (mouse + cage) can be computationally heavy and may need specialized packages (`glmmTMB`, `MCMCglmm`). Convergence may be an issue with only 20 mice. |
| **PERMANOVA** | Non‑parametric, so normality not required. Must block permutations by mouse (to respect repeated measures) and optionally by cage. With only 10 mice per group, the number of unique permutations is limited, but still usually sufficient (≥ 1000 permutations). Need to check homogeneity of dispersions (PERMDISP); cage effects could inflate dispersion within groups. |
| **Mixed‑effects on PCoA axes** | Same zero‑handling issue as LMM (need distance metric that can handle zeros, e.g., Bray‑Curtis). Reducing to few axes may lose information; inference on each axis separately ignores covariance among axes unless a multivariate approach is used. |
| **Bayesian hierarchical logistic‑normal** | Naturally accommodates zeros via the latent normal layer; can include mouse and cage random effects. Requires careful prior specification and MCMC diagnostics; with small N, posterior may be sensitive to priors, but this can be mitigated with weakly informative priors. Computationally feasible with `brms`/`stan`. |
| **ANCOM‑BC / dream** | ANCOM‑BC assumes approximately normal log‑ratios after bias correction; works well with moderate sparsity. `dream` (from `variancePartition`) extends linear mixed models to RNA‑seq‑style data and can handle random effects; still relies on normality of log‑transformed counts. Zero handling requires offset or filtering low‑abundance taxa. |

**Step 4 – Practical considerations**

| Factor | Influence on choice |
|--------|---------------------|
| **Software availability & familiarity** | Most labs have R with `lme4`, `glmmTMB`, `vegan` (PERMANOVA), `phyloseq`/`microbiome` (CLR, ANCOM‑BC), `brms`/`rstan` (Bayesian). If the analyst is comfortable with mixed models, LMM/GLMM routes are quick; if they prefer permutation tests, PERMANOVA is easy. |
| **Interpretability** | LMM on CLR gives effect sizes on log‑ratio scale (easily back‑transformed to fold‑changes). PERMANOVA gives a pseudo‑F statistic and p‑value but no direct effect size for individual taxa. Bayesian models give full posterior distributions, useful for uncertainty quantification but require more explanation. |
| **Field conventions** | Microbiome longitudinal studies often use: (i) PERMANOVA for overall community shifts, (ii) ANCOM‑BC or `DESeq2`/`dream` for taxon‑level tests, (iii) mixed‑effects models on CLR‑transformed data for specific hypotheses. Reporting multiple complementary approaches is increasingly accepted. |
| **Sample size & power** | With N = 20, permutation‑based methods (PERMANOVA) are robust to small‑sample asymptotics. Model‑based GLMM/LMM may suffer from biased variance estimates; using restricted maximum likelihood (REML) and Kenward‑Roger or Satterthwaite df adjustments can help. Bayesian approaches can borrow strength across taxa via hierarchical priors, improving power. |
| **Handling cage effects** | Including cage as a random effect is straightforward in LMM/GLMM/Bayesian frames. In PERMANOVA, cage can be used as a stratification factor (i.e., permute within cages) or as a blocking term in a stratified adonis2. |
| **Zero‑inflation** | Methods that model counts directly (Dirichlet‑multinomial GLMM, Bayesian logistic‑normal) or use appropriate transformations (CLR with multiplicative replacement) avoid spurious results from zeros. |

**Step 5 – Recommendation & questions for a statistician**

**Suggested approaches to discuss**

1. **Primary overall test:**  
   - *PERMANOVA (adonis2)* on a suitable distance matrix (e.g., Bray‑Curtis or weighted UniFrac) with **strata = mouseID** to respect repeated measures, and optionally **block = cageID** (or include cage as a stratification factor).  
   - Follow with *PERMDISP* to check homogeneity of dispersions; if violated, consider a distance metric less sensitive to dispersion or use a model‑based approach.

2. **Taxon‑level inference (if you need to know which taxa drive the effect):**  
   - *ANCOM‑BC* (or `dream` from `variancePartition`) with **fixed effects**: treatment, time, treatment:time; **random effects**: mouseID (intercept) and optionally cageID (intercept).  
   - Provide p‑values adjusted for multiple testing (e.g., BH FDR).  

3. **Model‑based complementary approach (for effect size estimation and to formally account for cage):**  
   - Fit a **Dirichlet‑multinomial GLMM** via `glmmTMB` (family = `dmultinom`) with random intercepts for mouseID and cageID, fixed effects for treatment, time, and their interaction.  
   - Alternatively, a **Bayesian logistic‑normal mixed model** using `brms`: `bf(cbind(taxa1, taxa2, ...) ~ treatment * time + (1|mouseID) + (1|cageID), family = dirichlet())`.  
   - Examine posterior credible intervals for the treatment:time interaction; report posterior probabilities or Bayes ratios.

**Specific questions to pose to the statistician**

1. **How should we handle the zero‑inflated compositional nature of the data?**  
   - Which transformation (CLR with multiplicative replacement, ALR, or raw counts) is most appropriate given our sparsity level?  

2. **What is the best way to incorporate the cage effect?**  
   - Should cage be modeled as a random intercept, a fixed effect, or used as a stratification/blocking factor in permutations?  

3. **Given our modest sample size (20 mice), which method offers the best balance between Type I error control and power?**  
   - Are there recommended df‑adjustment methods (Kenward‑Roger, Satterthwaite) for LMM/GLMM, or should we rely on permutation‑based p‑values?  

4. **How many permutations are feasible and sufficient for PERMANOVA with our blocking structure?**  
   - Can we safely use unrestricted permutations within mouseID, or do we need to restrict permutations within cage as well?  

5. **If we pursue a Bayesian hierarchical model, what priors would you recommend for the treatment effects and variance components?**  
   - How do we assess convergence and model fit (e.g., posterior predictive checks, LOO‑CV)?  

6. **Should we reduce dimensionality (e.g., PCoA) before applying mixed models, or model the full composition directly?**  
   - What are the trade‑offs in interpretability and information loss?  

7. **What multiple‑testing correction strategy do you advise for the taxon‑level tests (ANCOM‑BC/dream) given the correlated nature of taxa?**  
   - Are there alternatives (e.g., hierarchical FDR, tree‑based methods) that might be more powerful?  

By walking through these steps, you’ll have a clear set of candidate methods, an understanding of where each might falter with your specific design, and a concrete agenda for a statistical consultation. Good luck with your analysis!
```

## Assessment
_To be completed by a human reviewer. Do not mark Pass without reading the output._

### Task Achievement
- **Achieved:** [Yes / No / Partial]
- **Notes:**

### Constraint Compliance
- **All constraints respected:** [Yes / No]
- **Violations noted:**

### Failure Modes
- **Failure modes observed:** [None / list]
- **Mitigation effectiveness:**

### Output Format
- **Format correct:** [Yes / No]
- **Deviations:**

## Overall Assessment
- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:**

## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
